Glenmark Life Sciences Ltd
GLSGlenmark Life Sciences Ltd
GLSPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
21.89 | 4.82 | 2.67% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
49.67 | 5.98 | 0.58% |
Forecast & Ratings
Detailed Forecastfrom 4 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Glenmark Life Sciences Ltd is a manufacturer of pharmaceutical preparation. The Company was founded in June 2011 and is located in Solapur, India.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 0.25 | 886.86 | 1,549.30 | 1,885.98 | 2,137.91 | 2,190.18 | 2,295.26 | 2,295.26 | ||||||||
Raw Materials | 0.04 | 633.56 | 668.66 | 948.17 | 977.96 | 1,068.56 | 1,608.97 | 1,608.97 | ||||||||
Power & Fuel Cost | 0.00 | 57.81 | 76.75 | 74.19 | 100.92 | 115.60 | ||||||||||
Employee Cost | 0.15 | 106.28 | 142.28 | 149.13 | 168.72 | 180.18 | ||||||||||
Selling & Administrative Expenses | 0.00 | 44.20 | 42.05 | 48.50 | 48.64 | 65.99 | ||||||||||
Operating & Other expenses | 0.08 | -203.15 | 135.61 | 74.11 | 210.91 | 88.59 | ||||||||||
EBITDA | -0.02 | 248.16 | 483.95 | 591.88 | 630.76 | 671.26 | 686.29 | 686.29 | ||||||||
Depreciation/Amortization | 0.00 | 19.26 | 29.37 | 33.39 | 37.88 | 42.09 | 53.45 | 53.45 | ||||||||
PBIT | -0.02 | 228.90 | 454.58 | 558.49 | 592.88 | 629.17 | 632.84 | 632.84 | ||||||||
Interest & Other Items | 0.00 | 0.61 | 33.52 | 87.55 | 27.96 | 0.55 | 1.55 | 1.55 | ||||||||
PBT | -0.02 | 228.29 | 421.06 | 470.94 | 564.92 | 628.62 | 631.29 | 631.29 | ||||||||
Taxes & Other Items | 0.42 | 32.71 | 107.97 | 119.37 | 146.20 | 161.65 | 160.40 | 160.41 | ||||||||
Net Income | -0.44 | 195.58 | 313.09 | 351.57 | 418.72 | 466.97 | 470.89 | 470.88 | ||||||||
EPS | -8.00 | 36.10 | 29.04 | 32.61 | 36.36 | 38.11 | 38.43 | 38.43 | ||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 21.00 | 42.00 | 22.50 | 22.50 | ||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.58 | 1.10 | 0.59 | 0.59 |
Company Updates
Investor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Glenmark Life Sciences Ltd | 21.89 | 4.82 | 2.67% |
Sun Pharmaceutical Industries Ltd | 43.01 | 6.14 | 0.76% |
Cipla Ltd | 40.92 | 4.83 | 0.60% |
Dr Reddy's Laboratories Ltd | 18.77 | 4.50 | 0.64% |
Price Comparison
Compare GLS with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Glenmark Life Sciences Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
UNION MULTICAP FUND-DIRECT PLAN-GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.1055% | Percentage of the fund’s portfolio invested in the stock 1.31% | Change in the portfolio weight of the stock over the last 3 months 0.23% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 9/110 (+10) |
Union Innovation & Opportunities Fund - Direct Plan - Growth Option Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0930% | Percentage of the fund’s portfolio invested in the stock 1.59% | Change in the portfolio weight of the stock over the last 3 months 1.59% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 34/56 (+18) |
Old Bridge Focused Equity Fund - Direct Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0820% | Percentage of the fund’s portfolio invested in the stock 3.78% | Change in the portfolio weight of the stock over the last 3 months 3.78% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 16/23 (-10) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateOct 17, 2023
Dividend/Share
₹22.50
Ex DateEx Date
Oct 17, 2023
Cash Dividend
Ex DateEx DateMar 24, 2023
Dividend/Share
₹21.00
Ex DateEx Date
Mar 24, 2023
Cash Dividend
Ex DateEx DateSep 15, 2022
Dividend/Share
₹10.50
Ex DateEx Date
Sep 15, 2022
Cash Dividend
Ex DateEx DateNov 22, 2021
Dividend/Share
₹10.50
Ex DateEx Date
Nov 22, 2021
News & Opinions
#AskBQ: Nirma To Acquire 75% In Glenmark Life Sciences
7 months ago•Bloomberg Quint
Glenmark Pharma Shares Fall As It Plans To Sell Life Sciences Business
7 months ago•Bloomberg Quint
News Video
Key Stocks In Focus: Glenmark Life Sciences, Wipro, IdeaForge Tech, ICCI Lombard, ICCI Securities
7 months ago•CNBC-TV18
Glenmark Agrees To Sell 75% In Life Sciences Unit To Nirma For Rs 5,652 Crore
7 months ago•Bloomberg Quint
News Video
Glenmark Pharma To Sell 75% Stake In Glenmark Life | BQ Prime
7 months ago•BQ Prime
ChrysCapital still in race to buy controlling stake in Glenmark Life Sciences
8 months ago•Economic Times
Glenmark Pharma looking to divest 8 per cent in Glenmark Life Sciences
8 months ago•The Hindu Businessline
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 514.48%, vs industry avg of 8.36%
Increasing Market Share
Over the last 5 years, market share increased from 0% to 0.67%